Baergic Bio is a biopharmaceutical company that develops and commercialises novel therapeutics for the treatment of CNS disorders.Baergic Bio, Inc. is a biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of CNS disorders. Baergic Bio’s lead asset, BAER-101, is a novel α2/3–subtype-selective GABA A positive allosteric modulator currently being explored in both...
Baergic Bio is a biopharmaceutical company that develops and commercialises novel therapeutics for the treatment of CNS disorders.Baergic Bio, Inc. is a biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of CNS disorders. Baergic Bio’s lead asset, BAER-101, is a novel α2/3–subtype-selective GABA A positive allosteric modulator currently being explored in both a clinical and pre-clinical setting in areas of unmet need.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.